WallStreetZen

NASDAQ: AMED
Amedisys Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AMED

Based on 10 analysts offering 12 month price targets for Amedisys Inc.
Min Forecast
$181.00+32.41%
Avg Forecast
$220.20+61.08%
Max Forecast
$340.00+148.72%

Should I buy or sell AMED stock?

Based on 10 analysts offering ratings for Amedisys Inc.
Buy
Strong Buy
3 analysts 30%
Buy
4 analysts 40%
Hold
3 analysts 30%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

AMED stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Raymond James
Top 16%
85
BuyMaintains$225.00+64.59%2021-11-08
Credit Suisse
Bottom 7%
7
BuyMaintains$205.00+49.96%2021-11-04
Stephens & Co.
Top 17%
84
HoldMaintains$185.00+35.33%2021-11-04
RBC Capital
Bottom 4%
4
BuyMaintains$221.00+61.67%2021-11-04
SVB Leerink
Top 36%
65
HoldMaintains$181.00+32.41%2021-11-04
Oppenheimer
Top 45%
56
BuyMaintains$225.00+64.59%2021-11-03
Truist Securities
Top 15%
86
Strong BuyMaintains$190.00+38.99%2021-10-13
Anonymous
UBS
Strong SellInitiates Coverage On$150.00+9.73%2021-09-24
Cowen & Co.
Bottom 4%
4
HoldInitiates Coverage On$195.00+42.65%2021-09-10
Benchmark
Top 6%
95
Strong BuyMaintains$235.00+71.91%2021-08-10

1 of 2

Forecast return on equity

Is AMED forecast to generate an efficient return?
Company
N/A
Industry
4.52%
Market
37.5%

Forecast return on assets

Is AMED forecast to generate an efficient return on assets?
Company
N/A
Industry
0.08%

AMED earnings per share forecast

What is AMED's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$6.08-9.79%
Avg 2 year Forecast
$6.50-3.56%
Avg 3 year Forecast
$7.86+16.62%
AMED's earnings are forecast to grow at a rate of 3.81% per year, which is not exceptional
Forecast

AMED revenue forecast

What is AMED's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$2.2B-0.04%
Avg 2 year Forecast
$2.4B+7.16%
Avg 3 year Forecast
$2.6B+17.89%
AMED's revenue is forecast to grow at a rate of 5.34% per year, which is not exceptional
Forecast

AMED earnings growth forecast

How is AMED forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
3.81%
Industry
1.34%
Market
14.37%
AMED's earnings are forecast to grow faster (3.81% per year) than the US Medical Care Facilities industry average (1.34%)
Forecast
AMED's earnings are forecast to grow slower (3.81% per year) than the US market average (14.37%)
Forecast
AMED's earnings are forecast to grow faster (3.81% per year) than the risk-free savings rate (1.4%)
Forecast

AMED revenue growth forecast

How is AMED forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
5.34%
Industry
6.87%
Market
10.08%
AMED's revenues are forecast to grow slower (5.34% per year) than the US Medical Care Facilities industry average (6.87%)
Forecast
AMED's revenues are forecast to grow slower (5.34% per year) than the US market average (10.08%)
Forecast

Amedisys Stock Forecast FAQ

Is Amedisys Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: AMED) stock is to Buy AMED stock.

Out of 10 analysts, 3 (30%) are recommending AMED as a Strong Buy, 4 (40%) are recommending AMED as a Buy, 3 (30%) are recommending AMED as a Hold, 0 (0%) are recommending AMED as a Sell, and 0 (0%) are recommending AMED as a Strong Sell.

What is AMED's earnings growth forecast for 2021-2023?

(NASDAQ: AMED) Amedisys's forecast annual earnings growth rate of 3.81% is forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 1.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Amedisys's earnings in 2021 is $220,176,000.On average, 7 Wall Street analysts forecast AMED's earnings for 2021 to be $198,222,744, with the lowest AMED earnings forecast at $196,918,647, and the highest AMED earnings forecast at $199,526,841. On average, 8 Wall Street analysts forecast AMED's earnings for 2022 to be $211,915,763, with the lowest AMED earnings forecast at $195,940,574, and the highest AMED earnings forecast at $221,696,490.

In 2023, AMED is forecast to generate $256,255,061 in earnings, with the lowest earnings forecast at $243,866,139 and the highest earnings forecast at $263,101,570.

What is AMED's revenue growth forecast for 2021-2023?

(NASDAQ: AMED) Amedisys's forecast annual revenue growth rate of 5.34% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Amedisys's revenue in 2021 is $2,205,500,000.On average, 8 Wall Street analysts forecast AMED's revenue for 2021 to be $71,878,664,205, with the lowest AMED revenue forecast at $71,709,033,788, and the highest AMED revenue forecast at $72,224,152,103. On average, 8 Wall Street analysts forecast AMED's revenue for 2022 to be $77,055,212,041, with the lowest AMED revenue forecast at $74,936,673,863, and the highest AMED revenue forecast at $78,500,118,915.

In 2023, AMED is forecast to generate $84,771,521,388 in revenue, with the lowest revenue forecast at $83,299,195,875 and the highest revenue forecast at $85,486,818,593.

What is AMED's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: AMED) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of 0.08%.

What is AMED's Price Target?

According to 10 Wall Street analysts that have issued a 1 year AMED price target, the average AMED price target is $220.20, with the highest AMED stock price forecast at $340.00 and the lowest AMED stock price forecast at $181.00.

On average, Wall Street analysts predict that Amedisys's share price could stay at $220.20 by Nov 8, 2022. The average Amedisys stock price prediction forecasts a potential downside of N/A from the current AMED share price of $136.70.

What is AMED's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: AMED) Amedisys's current Earnings Per Share (EPS) is $6.74. On average, analysts forecast that AMED's EPS will be $6.08 for 2021, with the lowest EPS forecast at $6.04, and the highest EPS forecast at $6.12. On average, analysts forecast that AMED's EPS will be $6.50 for 2022, with the lowest EPS forecast at $6.01, and the highest EPS forecast at $6.80. In 2023, AMED's EPS is forecast to hit $7.86 (min: $7.48, max: $8.07).

What is AMED's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: AMED) forecast ROE is N/A, which is considered weak.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.